Top 10 US Stock Losers (11.9)
View all comments(0)
NASDAQ Composite Index has rose 2.74%, with a year-to-date rose 8.7%; S&P 500 has rose 2.35%, with a year-to-date rose 10.3%; Dow Jones Industrial Average has rose 2.15%, with a year-to-date rose 9%.
Janux Therapeutics(JANX) fell 27.62%, with a trading turnover 64.8 Million USD, and a year-to-date fell 7.5%.
Acadia Pharma(ACAD) fell 22.28%, with a trading turnover 214.8 Million USD, and a year-to-date fell 38.2%.
Ionis Pharma(IONS) fell 21.36%, with a trading turnover 581.4 Million USD, and a year-to-date fell 60.8%.
| Stock | Change | Turnover | Market Cap | YTD Change |
|---|---|---|---|---|
| Janux Therapeutics(JANX) | -27.62% | 64.8 Million USD | 780.7 Million USD | -7.5% |
| Acadia Pharma(ACAD) | -22.28% | 214.8 Million USD | 2.9 Billion USD | -38.2% |
| Ionis Pharma(IONS) | -21.36% | 581.4 Million USD | 5.2 Billion USD | -60.8% |
| ImmunityBio(IBRX) | -17.66% | 310.3 Million USD | 7.5 Billion USD | +259.1% |
| ArrowHead Pharma(ARWR) | -15.34% | 391.6 Million USD | 7.0 Billion USD | -25.8% |
| Shoals Tech(SHLS) | -13.49% | 79.2 Million USD | 1.5 Billion USD | +2.6% |
| Hims & Hers Health(HIMS) | -11.77% | 1.1 Billion USD | 5.4 Billion USD | -29.4% |
| Array Tech(ARRY) | -11.36% | 78.4 Million USD | 800.7 Million USD | -43.7% |
| Monday.com(MNDY) | -9.10% | 254.1 Million USD | 4.1 Billion USD | -45.8% |
| Calumet(CLMT) | -9.03% | 110.2 Million USD | 3.2 Billion USD | +81.5% |

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?

DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video

Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?

Cisco Stock Retests $101.60 Ahead of Q1 Results, With AI Orders in Focus

Nebius Plunges 15% as $7.3 Billion Capex Sparks Concern Despite 571% Q3 Revenue Surge







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.